SCHEMBL6504952

SCHEMBL6504952

COc1ccc(OC)c2c1C(=O)c1c-2n(C)c2ccc(O)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WEE1 P30291 1/20 0.41
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 2/20 0.39
S1PR4 O95977 1/20 0.39
HSP90AA1 P07900 1/20 0.39
G6PD P11413 1/20 0.39
S1PR1 P21453 1/20 0.39
MAPK1 P28482 1/20 0.39
OPRK1 P41145 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39
MCL1 Q07820 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6505681 0.84 NTRK1 (0.43) WEE1KDM4EALDH1A1LMNAGAA
SCHEMBL6498760 0.82 WEE1 (0.48) WEE1TDP1
SCHEMBL19330830 0.75 MAPT (0.55) WEE1KDM4EALDH1A1GAAHPGD
SCHEMBL6506227 0.69 WEE1 (0.48) WEE1KDM4EALDH1A1LMNAGAA
SCHEMBL6495062 0.69 WEE1 (0.50) WEE1TDP1
SCHEMBL11134106 0.69 MAPT (0.73) KDM4EALDH1A1LMNAGAAHPGD
SCHEMBL11263413 0.69 CHEK1 (0.44) WEE1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL6504264 0.68 PTGDR2 (0.41) WEE1ALDH1A1GAAMAPTTDP1
SCHEMBL6503691 0.67 TDP1 (0.40) WEE1L3MBTL1GAAHPGDMAPT
SCHEMBL6505751 0.67 PTGDR2 (0.41) WEE1ALDH1A1GAAMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6844445-B2 Indenoindolone compounds LES LABORATOIRES SERVIER (FR) 2005-01-18 US disclosed
EP-1245565-B1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2003-09-24 EP disclosed
US-20020173531-A1 Indenoindolone compounds LES LABORATOIRES SERVIER (FR) 2002-11-21 US disclosed
EP-1245565-A1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2002-10-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173531-A1 Indenoindolone compounds MTNR1A, MTNR1B, CYP11B1 WEE1 3618/4885KDM4E 3234/4885ALDH1A1 232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.